PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,125 | -52.7% | 2,713 | -36.2% | 0.00% | – |
Q2 2023 | $59,408 | +5410.9% | 4,251 | +2715.2% | 0.00% | – |
Q1 2023 | $1,078 | -46.1% | 151 | +0.7% | 0.00% | – |
Q4 2022 | $2,000 | -66.7% | 150 | -72.7% | 0.00% | – |
Q3 2022 | $6,000 | -94.3% | 550 | -95.6% | 0.00% | – |
Q2 2022 | $106,000 | -83.9% | 12,561 | -74.1% | 0.00% | -100.0% |
Q1 2022 | $659,000 | +488.4% | 48,415 | +754.2% | 0.00% | – |
Q4 2021 | $112,000 | +67.2% | 5,668 | +173.0% | 0.00% | – |
Q3 2021 | $67,000 | +63.4% | 2,076 | +69.7% | 0.00% | – |
Q2 2021 | $41,000 | -10.9% | 1,223 | 0.0% | 0.00% | – |
Q1 2021 | $46,000 | +12.2% | 1,223 | 0.0% | 0.00% | – |
Q4 2020 | $41,000 | -8.9% | 1,223 | 0.0% | 0.00% | – |
Q3 2020 | $45,000 | +80.0% | 1,223 | +63.1% | 0.00% | – |
Q2 2020 | $25,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 2,484,274 | $27,873,554 | 11.71% |
Frazier Life Sciences Management, L.P. | 8,407,152 | $94,328,245 | 5.86% |
Abingworth LLP | 1,435,106 | $16,101,889 | 5.25% |
Opaleye Management Inc. | 417,500 | $4,684,350 | 1.63% |
683 Capital Management, LLC | 1,350,000 | $15,147,000 | 1.28% |
Newtyn Management, LLC | 484,074 | $5,431,310 | 1.12% |
Penn Mutual Asset Management | 62,802 | $704,638 | 0.79% |
StepStone Group LP | 422,085 | $4,735,794 | 0.62% |
MPM BioImpact LLC | 195,942 | $2,198,469 | 0.57% |
Avidity Partners Management LP | 1,900,000 | $21,318,000 | 0.46% |